Filter posts

Notable Limitations of the Latest Drug Pricing Report

In a new report, Sen. Claire McCaskill, the ranking Democratic lawmaker on the Senate Homeland …

#BIOCEO18: A Bright Future

“A transformative year in medicine.” That’s how BIO President and CEO Jim Greenwood recently described …

#BIOCEO18: “A Moment Decades in the Making”

It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking …

“A Transformative Year in Medicine”

2017 will be remembered as an exciting year for biopharmaceutical innovation. Not only did we …

Insurers Distort the Facts on Drug Costs … Again

An effort by the Blue Cross Blue Shield Association (BCBSA) to spur a discussion on …

A Flawed Bill That Would Harm Seniors

The Medicare prescription drug program has been a remarkable success for both seniors and taxpayers, …

A Discussion on Value at #BIF17

In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend …

“Invest in What’s Cool. Invest in Science that Matters.”

One reality of the biotech industry that’s often overlooked is that 90% of biotech companies …

For Today’s Hearing on the Drug Delivery System, ‘Follow The Pill’

The Senate Committee on Health, Education, Labor, and Pensions will hold a hearing this morning …

New Infographic: The Bayh-Dole Act

$1.3 trillion in economic output. Support for roughly 4.2 million jobs. The creation of more …